O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 8.65 GBX 1.76%
Market Cap: 34.9m GBX
Have any thoughts about
Ondine Biomedical Inc?
Write Note

Ondine Biomedical Inc
Investor Relations

Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-12-06. The firm is focused on developing products that utilizes its light-activated technology, primarily for the healthcare-associated infection (HAI) market. Photodisinfection provides a spectrum of antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance. The company offers solution in Steriwave Nasal Decolonization (ND) and SurgENT. Steriwave ND provides a spectrum antimicrobial providing targeted decolonization. SurgENT is a tool for cleaning and irrigating the paranasal sinuses. The intrasinus balloon design directs irrigant circumferentially around the sinus walls, maintaining debridement pressure.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Ms. Carolyn M. Cross C.F.A., CFA, M.B.A., MBA
Founder, CEO & Executive Director
No Bio Available
Dr. Nicolas G. Loebel Ph.D.
President, CTO & Executive Director
No Bio Available
Mr. Kwong Choo CPA, CIMA
Interim Chief Financial Officer
No Bio Available
Mr. William Kanz
Senior VP of Engineering & Operations
No Bio Available
Ms. Angelika Vance
Vice President of Corporate Communications
No Bio Available
Mr. Matt Ross
Vice President of Sales & Marketing
No Bio Available
Ms. Elaine Lei CPA
Corporate Controller
No Bio Available
Mr. Nikita Parkev
VP of Finance & Company Secretary
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
888-1100 Melville St
Contacts
+16046690555.0
www.ondinebio.com